Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. News
  7. Summary
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
170.14 USD   -2.24%
05:46aANALYST RECOMMENDATIONS : Coca-Cola, Dollar General, Comcast, Deliveroo, Seagen...
MS
05:15aSVB Securities Adjusts Seagen's Price Target to $152 From $159, Keeps Outperform Rating
MT
02:54aJapan Index Rallies on Upbeat Economic Reports; Daiichi Sankyo Soars 14% on Legal Victory
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Seagen

07/01/2022 | 07:11am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about SEAGEN INC.
05:46aANALYST RECOMMENDATIONS : Coca-Cola, Dollar General, Comcast, Deliveroo, Seagen...
MS
05:15aSVB Securities Adjusts Seagen's Price Target to $152 From $159, Keeps Outperform Rating
MT
02:54aJapan Index Rallies on Upbeat Economic Reports; Daiichi Sankyo Soars 14% on Legal Victo..
MT
02:38aNikkei hits over 7-month high on Wall Street optimism, robust earnings
RE
08/14Japanese shares rise on Wall Street optimism, strong earnings
RE
08/14Daiichi Sankyo Shares Gain After It Wins Dispute Over Cancer Drug Technology
DJ
08/12SEAGEN : Statement on Outcome of Daiichi Sankyo Arbitration - Form 8-K
PU
08/12SEAGEN INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/12Seagen Loses Arbitration Against Daiichi Sankyo; Sees No Impact on Existing Business
MT
08/12Seagen loses arbitration against Daiichi Sankyo over drug technology
RE
More news
Analyst Recommendations on SEAGEN INC.
More recommendations
Financials (USD)
Sales 2022 1 841 M - -
Net income 2022 -639 M - -
Net cash 2022 1 472 M - -
P/E ratio 2022 -49,0x
Yield 2022 -
Capitalization 31 380 M 31 380 M -
EV / Sales 2022 16,2x
EV / Sales 2023 11,8x
Nbr of Employees 2 675
Free-Float 99,2%
Chart SEAGEN INC.
Duration : Period :
Seagen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEAGEN INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 170,14 $
Average target price 182,62 $
Spread / Average Target 7,33%
EPS Revisions
Managers and Directors
Roger D. Dansey Chief Executive & Medical Officer
Todd E. Simpson Chief Financial Officer
Felix James Baker Chairman
Vaughn B. Himes Chief Technical Officer
David W. Gryska Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SEAGEN INC.10.05%31 380
MODERNA, INC.-32.60%66 966
IQVIA HOLDINGS INC.-12.88%45 846
LONZA GROUP AG-25.13%44 851
ALNYLAM PHARMACEUTICALS, INC.37.90%28 068
CELLTRION, INC.5.05%21 967